| Period Ending: |
LTM
(Last Twelve Months) |
2021 12-31 |
|---|---|---|
| Report Filing | 2022-11-18 | 2022-04-13 |
| Revenue | 0 | 0 |
| Cost of Revenue | 0 | 0 |
| Gross Profit | 0 | 0 |
| Operating Expenses | 3.76 | 3.73 |
| Research & Development | 0 | 0 |
| Selling, General and Administrative | 3.76 | 3.73 |
| Other Operating Expenses | -0 | 0 |
| Operating Income | -3.76 | -3.73 |
| Net Non-Operating Interest | 2.24 | 0.042 |
| Interest Income | 2.24 | 0.042 |
| Interest Expense | 0 | 0 |
| Equity & Other Income/(Expense) | 14.4 | 3.17 |
| Income Before Tax | 12.88 | -0.524 |
| Income Tax Expense | -16.65 | -3.21 |
| Income Attributable to Non-Controlling Interest | 0.001 | 0 |
| Net Income | 29.53 | 2.69 |
| Depreciation and Amortization | 16.65 | 0 |
| EBITDA | 12.88 | -3.73 |
| Earnings Per Share (EPS) | 0.692 | 0.068 |
| Diluted Earnings Per Share | 0.692 | 0.068 |
| Weighted Average Shares Outstanding | 43.12 | 39.32 |
| Diluted Weighted Average Shares Outstanding | 43.12 | 39.32 |
